Orbitrap ID-X Tribrid Mass Spectrometer for Unbiased Global Metabolomics Profiling
Orbitrap ID-X Tribrid Mass Spectrometer for Unbiased Global Metabolomics Profiling
批准号:
10415529
负责人:
Arun Sreekumar
金额:
$78.97万
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
已结题
起止时间:
2022-09-22 至 2023-09-21
关键词:
Advisory CommitteesAreaBiological MarkersCell LineClinicalComputer softwareContract ServicesDiabetes MellitusEnvironmental ExposureFundingGoalsHuman ResourcesInstitutionInvestigationLinkMalignant NeoplasmsMedicineMetabolicMethodsMonitorObesityOutputPositioning AttributeResearch PersonnelResolutionServicesSpecimenTechnologyTestingTrainingTransgenic ModelVirus DiseasesXenograft procedurebasecollegecostinnovationmass spectrometermetabolomicsnovelnovel therapeutic interventionpatient derived xenograft modelpre-clinical
中文摘要
摘要
英文摘要
ABSTRACT
The goal of this S10 application is to request funding for a high resolution Orbitrap ID-X Tribrid mass
spectrometer (OT IDX) to enable identification and quantification of global metabolite profiles in various
biospecimens. This will fill a “missing link” in the Metabolomics Core at Baylor College of Medicine that has to
date, excelled in offering targeted metabolic profiling platforms to support scientific investigations. OT IDX will
be used to develop robust and well tested methods for profiling steady state levels of metabolites in a global
fashion as well as changes in metabolic flux in a global scale. These technologies that will be offered as a new
line of service in the Metabolomics Core will support studies using pre-clinical specimens (cell line-derived
xenografts, patient-derived xenografts and transgenic models), clinical specimens and cell lines. Importantly, the
unbiased technologies will support projects in the areas of Cancer, Diabetes, Obesity, Environmental Exposures,
Viral infections, etc. The OT IDX will be administered by the Baylor Metabolomics Core under the Advanced
Technology Core Umbrella. The installation, and implementation of OT IDX will be significantly supported by the
institutional funding that will cover personnel, Service Contract, software and training costs. The functioning and
output of the OT IDX will be monitored by the Internal Advisory Committee and External Advisory Committee,
which have experts in metabolomics, Core leaders and institutional representatives. Based on the outstanding
track record of the Metabolomics Core at Baylor College of Medicine, the Core is strongly positioned to establish
the innovative unbiased global metabolic platform using OT IDX in the institution. This will allow investigators to
develop novel hypothesis and leads that could culminate in new biomarkers and novel therapeutic interventions.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Rewired Metabolism Regulates Vessel Normalization and Immunosuppression
-
批准号:9888335
-
项目类别:
-
资助金额:$61.83万
-
财政年份:2019
-
负责人:Arun Sreekumar
-
依托单位:
Rewired Metabolism Regulates Vessel Normalization and Immunosuppression
-
批准号:10232056
-
项目类别:
-
资助金额:$41.55万
-
财政年份:2019
-
负责人:Arun Sreekumar
-
依托单位:
Rewired Metabolism Regulates Vessel Normalization and Immunosuppression
-
批准号:10674493
-
项目类别:
-
资助金额:$40.72万
-
财政年份:2019
-
负责人:Arun Sreekumar
-
依托单位:
Rewired Metabolism Regulates Vessel Normalization and Immunosuppression
-
批准号:10474320
-
项目类别:
-
资助金额:$40.72万
-
财政年份:2019
-
负责人:Arun Sreekumar
-
依托单位:
Core B (Metabolomics Component)
-
批准号:10153759
-
项目类别:
-
资助金额:$15.85万
-
财政年份:2018
-
负责人:Arun Sreekumar
-
依托单位:
Core B (Metabolomics Component)
-
批准号:10421281
-
项目类别:
-
资助金额:$15.85万
-
财政年份:2018
-
负责人:Arun Sreekumar
-
依托单位:
Delineating racially distinct metabolic pathways in triple negative breast cancer
-
批准号:9120349
-
项目类别:
-
资助金额:$33.52万
-
财政年份:2014
-
负责人:Arun Sreekumar
-
依托单位:
High Kynurenine in Agressive Triple Negative African American Breast Cancer
-
批准号:8843400
-
项目类别:
-
资助金额:$17.02万
-
财政年份:2014
-
负责人:Arun Sreekumar
-
依托单位:
High Kynurenine in Agressive Triple Negative African American Breast Cancer
-
批准号:8687235
-
项目类别:
-
资助金额:$20.42万
-
财政年份:2014
-
负责人:Arun Sreekumar
-
依托单位:
Metabolomic Markers for Early Detection of Prostate Cancer
-
批准号:7657959
-
项目类别:
-
资助金额:$7.35万
-
财政年份:2009
-
负责人:Arun Sreekumar
-
依托单位:
Metabolomic Markers for Early Detection of Prostate Cancer
-
批准号:7893626
-
项目类别:
-
资助金额:$2.94万
-
财政年份:2009
-
负责人:Arun Sreekumar
-
依托单位:
Metabolomic Markers for Early Detection of Prostate Cancer
-
批准号:8247902
-
项目类别:
-
资助金额:$4.41万
-
财政年份:2009
-
负责人:Arun Sreekumar
-
依托单位:
Integrative Metabolomics of Prostate Cancer Progression
-
批准号:7603104
-
项目类别:
-
资助金额:$32.05万
-
财政年份:2008
-
负责人:Arun Sreekumar
-
依托单位:
Integrative Metabolomics of Prostate Cancer Progression
-
批准号:8018504
-
项目类别:
-
资助金额:$32.84万
-
财政年份:2008
-
负责人:Arun Sreekumar
-
依托单位:
Integrative Metabolomics of Prostate Cancer Progression
-
批准号:8329459
-
项目类别:
-
资助金额:$31.45万
-
财政年份:2008
-
负责人:Arun Sreekumar
-
依托单位:
Integrative Metabolomics of Prostate Cancer Progression
-
批准号:7778817
-
项目类别:
-
资助金额:$30.88万
-
财政年份:2008
-
负责人:Arun Sreekumar
-
依托单位:
Shared Resource: Metabolomics
-
批准号:9759801
-
项目类别:
-
资助金额:$9.36万
-
财政年份:--
-
负责人:Arun Sreekumar
-
依托单位:
Core B (Metabolomics Component)
-
批准号:9975153
-
项目类别:
-
资助金额:$15.85万
-
财政年份:--
-
负责人:Arun Sreekumar
-
依托单位:
国内基金
海外基金
层出镰刀菌氮代谢调控因子AreA 介导伏马菌素 FB1 生物合成的作用机理
-
批准号:2021JJ40433
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2021
-
负责人:孙磊
-
依托单位:
寄主诱导梢腐病菌AreA和CYP51基因沉默增强甘蔗抗病性机制解析
-
批准号:32001603
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:段真珍
-
依托单位:
AREA国际经济模型的移植.改进和应用
-
批准号:18870435
-
项目类别:面上项目
-
资助金额:2.0万元
-
批准年份:1988
-
负责人:史树中
-
依托单位: